CCCC vs. KEEL

Last updated Jun 4, 2026

CCCC (C4 Therapeutics, Inc.) and KEEL (Keel Infrastructure Corporation) are both stocks. CCCC operates in Biotechnology (Healthcare), while KEEL operates in Capital Markets (Financial Services). Over the past 5 years, CCCC returned -36.72%/yr vs 6.42%/yr for KEEL. At a 0.30 correlation, their price movements are largely independent.

Performance

CCCC vs. KEEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in C4 Therapeutics, Inc. (CCCC) and Keel Infrastructure Corporation (KEEL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CCCC achieves a 107.33% return, which is significantly lower than KEEL's 161.70% return.

CCCC

• 1D: -8.76%
• 1M: 30.48%
• YTD: 107.33%
• 6M: 40.93%
• 1Y: 167.57%
• 3Y*: 5.32%
• 5Y*: -36.72%
• 10Y*: —

KEEL

• 1D: 0.16%
• 1M: 89.23%
• YTD: 161.70%
• 6M: 97.75%
• 1Y: 568.41%
• 3Y*: 71.93%
• 5Y*: 6.42%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CCCC vs. KEEL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CCCC C4 Therapeutics, Inc.	107.33%	-46.94%	-36.28%	-4.24%	-81.68%	-2.81%	29.97%
KEEL Keel Infrastructure Corporation	161.70%	57.72%	-48.80%	561.36%	-91.29%	165.79%	690.68%

Correlation

The correlation between CCCC and KEEL is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.30
Correlation (5Y) Calculated over the trailing 5-year period	0.32
Correlation (All Time) Calculated using the full available price history since Oct 5, 2020	0.30

Fundamentals

Market Cap CCCC : $499.26M KEEL : $3.39B
EPS CCCC : -$1.18 KEEL : -$0.51
PS Ratio CCCC : 12.16 KEEL : 14.88
PB Ratio CCCC : 2.13 KEEL : 6.05
Total Revenue (TTM) CCCC : $28.71M KEEL : $229.28M
Gross Profit (TTM) CCCC : $26.90M KEEL : -$18.90M
EBITDA (TTM) CCCC : -$107.31M KEEL : -$149.60M

Return for Risk

CCCC vs. KEEL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CCCC

CCCC Risk / Return Rank: 82
CCCC Sharpe Ratio Rank: 84
CCCC Sortino Ratio Rank: 85
CCCC Omega Ratio Rank: 79
CCCC Calmar Ratio Rank: 83
CCCC Martin Ratio Rank: 79

KEEL

KEEL Risk / Return Rank: 94
KEEL Sharpe Ratio Rank: 99
KEEL Sortino Ratio Rank: 95
KEEL Omega Ratio Rank: 92
KEEL Calmar Ratio Rank: 96
KEEL Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CCCC vs. KEEL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for C4 Therapeutics, Inc. (CCCC) and Keel Infrastructure Corporation (KEEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CCCC	KEEL	Difference
Sharpe ratio: Return per unit of total volatility	1.65	5.25	-3.60
Sortino ratio: Return per unit of downside risk	2.73	4.12	-1.38
Omega ratio: Gain probability vs. loss probability	1.30	1.49	-0.19
Calmar ratio: Return relative to maximum drawdown	3.24	7.79	-4.55
Martin ratio: Return relative to average drawdown	6.26	12.95	-6.69
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CCCC vs. KEEL - Sharpe Ratio Comparison

The current CCCC Sharpe Ratio is 1.65, which is lower than the KEEL Sharpe Ratio of 5.25. The chart below compares the historical Sharpe Ratios of CCCC and KEEL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CCCC	KEEL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.65	5.25	-3.60
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.31	0.06	-0.38
Sharpe Ratio (All Time) Calculated using the full available price history	-0.25	0.07	-0.32

Drawdowns

CCCC vs. KEEL - Drawdown Comparison

The maximum CCCC drawdown since its inception was -97.82%, roughly equal to the maximum KEEL drawdown of -95.72%. Use the drawdown chart below to compare losses from any high point for CCCC and KEEL.

Drawdown Indicators

	CCCC	KEEL	Difference
Max Drawdown Largest peak-to-trough decline	-97.82%	-95.72%	-2.10%
Max Drawdown (1Y) Largest decline over 1 year	-52.10%	-73.65%	+21.55%
Max Drawdown (3Y) Largest decline over 3 years	-90.00%	-81.04%	-8.96%
Max Drawdown (5Y) Largest decline over 5 years	-97.82%	-95.72%	-2.10%
Current Drawdown Current decline from peak	-92.16%	-30.67%	-61.49%
Average Drawdown Average peak-to-trough decline	-71.89%	-67.62%	-4.27%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.88%	44.18%	-17.30%

Volatility

CCCC vs. KEEL - Volatility Comparison

C4 Therapeutics, Inc. (CCCC) has a higher volatility of 30.82% compared to Keel Infrastructure Corporation (KEEL) at 25.62%. This indicates that CCCC's price experiences larger fluctuations and is considered to be riskier than KEEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CCCC	KEEL	Difference
Volatility (1M) Calculated over the trailing 1-month period	30.82%	25.62%	+5.20%
Volatility (6M) Calculated over the trailing 6-month period	65.20%	68.35%	-3.15%
Volatility (1Y) Calculated over the trailing 1-year period	102.98%	109.32%	-6.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	117.46%	104.76%	+12.70%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	113.16%	291.54%	-178.38%

Dividends

CCCC vs. KEEL - Dividend Comparison

Neither CCCC nor KEEL has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CCCC and KEEL in my portfolio?

CCCC and KEEL have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CCCC or KEEL?

CCCC has higher volatility (30.82%) compared to KEEL (25.62%). In terms of maximum drawdown, CCCC dropped -97.82% vs KEEL's -95.72%.

Which has better risk-adjusted returns?

KEEL currently has the higher Sharpe Ratio (5.25 vs 1.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.